On March 8, 2017, Vertiflex, a leading innovator of advanced, minimally invasive interventions for spinal stenosis, announced that it has closed a $40 million round of financing led by new investors Endeavour Vision and H.I.G. BioHealth Partners, with participation from existing investors New Enterprise Associates, Thomas, McNerney & Partners, and Alta Partners. Wilson Sonsini Goodrich & Rosati advised Vertiflex in the transaction.

According to a company press release, proceeds from the financing will primarily be used to fund U.S. commercial expansion of Vertiflex's Superion® Indirect Decompression System, a minimally invasive spinal implant designed to treat moderate lumbar spinal stenosis.

The WSGR team that advised Vertiflex in the transaction included partner Marty Waters and associate Meg Burton.

For more information, please see Vertiflex's press release.